Healthcare


Drug Discovery Technology Alert. Targeting Outer Mitochondrial Membrane Protein Activity for Improving Type II Diabetes Therapeutics; Triple Layer Microsphere for Effective Drug Delivery and Retention for Duodenum

Share this:

This issue profiles targeting outer mitochondrial membrane protein activity for improving type II diabetes therapeutics, a triple layer microsphere for effective drug delivery and retention for duodenum, and a small molecule that can prevent type I diabetes.

Click headings to expand and collapse Published: 18 Nov 2011

Tools

Features of this research

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..